However, they showed clear cytotoxicity to MG-63 cells at concentrations greater than 20 mg/mL
For weight management (Wegovy), the titration schedule is more gradual, starting at 0.25 mg weekly and increasing monthly (0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg) up to a maintenance dose of 2.4 mg weekly, to minimise gastrointestinal side effects
Hashimotos is a progressive autoimmune condition that results in the destruction of the thyroid gland and leads to hypothyroidism and in some cases, to other types of autoimmune conditions as well
For general background and systematic reviews see the overview at Healthline and detailed reviews on PubMed Central: PMC review and a trial-focused report PMC trial study
Long term risks While tirzepatide and semaglutide are effective in aiding weight loss, there are some long-term risks to be aware of
There is no official clinical guidance, published interaction data, or regulatory framework governing the combined use of AOD 9604 and retatrutide
